01 July 2005 : Original article
Hemochromatosis-causing mutations C282Y and H63D are not risk factors for atherothrombotic cerebral infarction.
Helena Hruskovicová, Tomaz Milanez, Jan Kobal, Karmen Peterlin Potisk, Danijel Petrovic, Borut PeterlinMed Sci Monit 2005; 11(7): BR248-252 :: ID: 16977
Abstract
Background: It has been suggested that iron metabolism may be involvedin the pathogenesis of atherothrombotic cerebral infarction (ACI). The C282Y and H63D mutations in thehemochromatosis (HFE) gene are associated with increased serum iron levels and net iron accumulation.The aim of this study was to test the hypothesis that the C282Y and H63D mutations in the HFE gene arerisk factors for ACI in a Slovene population. Material/Methods: The C282Y and H63D HFE gene mutationswere tested in 96 Caucasian patients who had suffered an acute cerebral infarction, later confirmed asACI, and 115 control subjects. Genotypes were determined by electrophoresis of the DNA digestion productsfrom RsaI (C282Y) and MboI (H63D). Results: We failed to demonstrate that the C282Y and H63D mutationswere risk factors for ACI in Caucasians. The percentage of C282Y and H63D genotypes (dominant model)in ACI-cases (C282Y: 7.3%, n=7; H63D: 28.1%, n=27) did not differ significantly (P=0.9 and P=0.7 respectively)from that of the controls (C282Y: 7.0%, n=8; H63D: 26.1%, n=30). Logistic regression analysis revealedthat arterial hypertension, diabetes, and cigarette smoking are independent risk factors for ACI, whereasthe C282Y and H63D HFE gene mutations are not. Conclusions: We provided evidence that the C282Y and H63DHFE gene mutations were not risk factors for ACI in this Slovene population.
Keywords: Intracranial Arteriosclerosis - genetics, Intracranial Thrombosis - complications, Intracranial Thrombosis - genetics, Cerebral Infarction - genetics, Diabetes Complications, Hemochromatosis - genetics, Hypertension - complications, Intracranial Arteriosclerosis - genetics, Intracranial Thrombosis - genetics, Mutation, Risk Factors, Slovenia, Smoking - adverse effects
Editorial
01 January 2026 : Editorial
Editorial: Increasing Awareness of Lung Cancer in Non-Smokers and Never-Smokers Challenges Current Approaches to Prevention and ScreeningDOI: 10.12659/MSM.952454
Med Sci Monit 2026; 32:e952454
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






